-
2025 HDBuzz Prize: MR-âwhyâ am I feeling this way? How MRI is helping us understand why people with HD may sometimes be unaware of their symptoms
Latest News
-
PROOF in the Publishing: Slicing the Data on Pridopidine
Pridopidine has been tested as a potential HD treatment over decades. The large PROOF-HD trial did not meet its main goals, but its results are now published. Publication makes the full data available, helping the HD community learn from the study.
-
The genetic 'gray area' of Huntington's disease: what does it all mean?
Intermediate alleles and reduced penetrance â the genetic 'gray area' of Huntingtonâs disease, explained
-
Dimebon fails in late-stage human HD clinical trial
Dimebon fails to improve symptoms in HD patients in the HORIZON trial
-
FDA: further trial needed for Huntexil approval in HD
Bad news for Huntexil â the FDA requires another trial before it can be approved in the US
-
Successful gene therapy trial in Parkinsonâs Disease gives hope for HD
Success for brain âgene therapyâ in Parkinsonâs disease â good news for similar treatments being developed in HD
-
Gene silencing for HD: the story so far
Is gene silencing as exciting as it sounds for HD, and what might the future hold?
-
Interview: Graeme Bilbe, Global Head for Neuroscience at Novartis
HDBuzz interviews Graeme Bilbe, Global Head for Neuroscience at pharmaceutical giant Novartis, about their HD researc
-
What do sheep brains have to do with HD?
How smart are sheep, and why do HD researchers care?
-
Interview: CHDI Management
HDBuzz interviews three top scientists from CHDI, the biggest funder and driver of HD research worldwide
-
CHDI Report: Day 3
Day 3 of CHDIâs HD therapeutics conference: growth factors and CHDIâs advanced therapies
-
CHDI Report: Day 2
Day 2 of CHDIâs HD therapeutics conference: figuring out energy problems in HD